Fundacion De Oftalmologia Medica De La Comunitat Valenciana

At Fundacion De Oftalmologia Medica De La Comunitat Valenciana, much of the research focuses on eye diseases and related ocular physiological phenomena. The trials examine conditions such as dry eye, meibomian gland dysfunction, atopic keratoconjunctivitis, vernal keratoconjunctivitis, persistent corneal epithelial defect, and age-related macular degeneration, with the goal of improving symptom control, healing, and overall eye health.

• Testing new approaches for dry eye disease and meibomian gland dysfunction
• Evaluating treatments for allergic eye conditions such as AKC and VKC
• Studying therapies aimed at supporting corneal repair and vision preservation
• Assessing options for retinal diseases including AMD and polypoidal choroidal vasculopathy

These studies are designed to measure how well new or existing therapies work, while also monitoring safety and patient comfort in everyday eye care.

The site also conducts trials in viral diseases and respiratory tract diseases, including research on respiratory syncytial virus and influenza immunisation. This work is centered on strengthening immune protection in older adults and understanding how well vaccines help prevent serious respiratory illness.

• Evaluating immune responses to RSV vaccination in older adults
• Assessing the safety and effectiveness of influenza vaccines
• Supporting prevention strategies for seasonal respiratory infections

These trials aim to improve protection against common but potentially serious infections, especially in populations at higher risk.

Research in bacterial infections at this patient organisation includes studies on pneumococcal disease and vaccine response. The main purpose is to evaluate whether newer vaccines can provide strong immune protection while remaining safe and well tolerated.

• Studying immune responses to pneumococcal vaccination
• Comparing vaccine performance in older adults
• Measuring protection against serious bacterial infection

By focusing on prevention, these trials help clarify how vaccination can reduce the burden of infections in the community.